The LKB1 tumor suppressor as a biomarker in mouse and human tissues.
Germline mutations in the LKB1 gene (also known as STK11) cause the Peutz-Jeghers Syndrome, and somatic loss of LKB1 has emerged as causal event in a wide range of human malignancies, including melanoma, lung cancer, and cervical cancer. The LKB1 protein is a serine-threonine kinase that phosphoryla...
Main Authors: | Yuji Nakada, Thomas G Stewart, Christopher G Peña, Song Zhang, Ni Zhao, Nabeel Bardeesy, Norman E Sharpless, Kwok-Kin Wong, D Neil Hayes, Diego H Castrillon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3783464?pdf=render |
Similar Items
-
Somatic LKB1 mutations promote cervical cancer progression.
by: Shana N Wingo, et al.
Published: (2009-01-01) -
Regulation of the tumor suppressor LKB1 by the acetyltransferase GCN5
by: Ghawitian, Maya
Published: (2015) -
Structure of the LKB1-STRAD-MO25 tumour suppressor complex
by: Zeqiraj, Elton
Published: (2009) -
The role of Lkb1 in preimplantation mouse embryos
by: Shafik, Marian
Published: (2013) -
The tumor suppressor LKB1 regulates starvation-induced autophagy under systemic metabolic stress
by: Laurie A. Mans, et al.
Published: (2017-08-01)